SCHEMBL19081559

SCHEMBL19081559

c1cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)cc(-c2cc3c4ccc5ccccc5c4oc3c3oc4ccccc4c23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A1 P04798 11/20 0.35
CYP1A2 P05177 11/20 0.35
CYP1B1 Q16678 11/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
PRKDC P78527 2/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
CYP2C19 P33261 2/20 0.35
PDE5A O76074 1/20 0.35
TP53 P04637 1/20 0.35
ABCB1 P08183 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081523 0.93 CYP1A1 (0.39) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL17944497 0.92 ALOX5 (0.40) ALOX5TDP1L3MBTL1CYP1A2KDM4E
SCHEMBL19076420 0.90 ALOX5 (0.43) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19081654 0.89 ARSA (0.39) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19080165 0.88 TDP1 (0.37) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL17944847 0.88 ALOX5 (0.41) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19076383 0.87 ALOX5 (0.36) ALOX5TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19076540 0.87 ALOX5 (0.41) ALOX5TDP1L3MBTL1KDM4EALDH1A1
SCHEMBL10122479 0.86 ALOX5 (0.46) ALOX5TDP1L3MBTL1KDM4EALDH1A1
SCHEMBL19081472 0.85 CYP1A1 (0.43) ALOX5TDP1L3MBTL1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.